abiraterone

On The Horizon – A Status Report of Six New Promising Advancing Treatments for Men with Advanced Prostate Cancer as of the Beginning of June, 2010

As of today there are many different potential drugs undergoing phase III evaluations for men with advanced prostate cancer, some of them seem to offer great hope and promise. Considering we just had Provenge finally approved, this is great news. […]

By Malecare|2010-06-08T09:15:34-04:00June 8th, 2010|abiraterone acetate, Advanced Prostate Cancer, Alpharadin (radium-223), Cabazitaxel, Chemo Therapy, Clinical Trials, Clinical Trials, Drugs & Treatments, FDA, General Information, Hormone Therapy, MDV3100, On The Horizon, Prostate Ponderings, Prostvac, Research, TAK700, Uncategorized, Understanding APC|3 Comments

The Excitement About Abiraterone – Maybe Our Future

The last few days have seen a lot of commotion and celebrating in the prostate cancer world. There have been multiple news stories of an experimental prostate cancer drug, abiraterone, that has been reported to dramatically shrink prostate cancer tumors and extend survival in 70 to 80 percent of men with aggressive prostate cancer. Abiraterone [...]

By Malecare|2020-02-04T10:12:26-05:00July 24th, 2008|Advanced Prostate Cancer, Clinical Trials, Drugs & Treatments, Hormone Therapy, Research, Uncategorized|0 Comments

Previous 56